Cell Therapy Market Witness High Growth To Cell Therapy Drugs
Cell Therapy Market |
The
global Cell Therapy Market is estimated to be valued at US$ 844.7 Mn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market Overview:
Cell therapy refers to the transplantation of human cells to replace or repair
damaged tissue or cells in the body. Cell therapy products help in curing
chronic diseases such as cancer, diabetes, cardiovascular disorders and
neurological disorders.
Market key trends:
One of the key trends in the cell therapy market is the increasing adoption of artificial
intelligence (AI). AI helps in processing large amounts of data related to
cells and patients history which further helps researcher in developing
personalized therapy. AI analyzes patterns in large data sets to help match
patients with therapies, determine best cell-processing methods and track
outcomes. This improves the success and reduces the cost of cell therapy
development and treatment over time.
Segment Analysis
The global cell therapy market is segmented based on therapy type, therapeutic
area, end user and region. By therapy type, the market is segmented into
allogeneic and autologous cell therapy. Currently, the allogeneic cell therapy
segment dominates the Cell
Therapy Market as allogenic cells not need to be harvested from the
patient and can be used directly thus reducing the overall treatment cost and
time with better availability.
Key Takeaways
The global cell therapy market is expected to witness high growth, exhibiting CAGR of 7.4% over the forecast period,
due to increasing prevalence of chronic diseases like cancer, diabetes,
cardiovascular diseases. The market size for 2023 is US$ 844.7 Mn
Regional analysis
North America dominates the global cell therapy market holding over 40% of the
market share. This is attributed to presence of advanced healthcare
infrastructure, favorable reimbursement policies and growth of biotechnology
and pharmaceutical industries in the region. Asia Pacific exhibits the fastest
growth rate over the forecast period due to rising healthcare expenditure,
increasing awareness about novel therapies and growth of biotech companies in
the region.
Key players
Key players operating in the cell therapy market are Stempeutics Research Pvt.
Ltd., Medipost Co. Ltd., Nipro Corporation, Dendreon Pharmaceuticals LLC,
Organogenesis Inc., Novartis AG, Vericel Corporation, Allogene Therapeutics
Inc., Gilead Sciences Inc. (Kite Pharma Inc.), and Takeda Pharmaceutical
Company Limited (TiGenix), among others. These players are focusing on
expanding their product portfolios through partnerships and collaborations to
strengthen their market position.
Read
More : https://www.marketwebjournal.com/cell-therapy-market-trends-forecast-growth/
Comments
Post a Comment